Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations

by Bosse, Kristopher R., Maris, John M.
Published in Cancer (2015)

Improving Patient Outcomes With Cancer Genomics: Unique Opportunities and Challenges in Pediatric Oncology

by Schnepp, Robert W., Bosse, Kristopher R., Maris, John M.
Published in JAMA (2015)

Suspected Posaconazole Toxicity in a Pediatric Oncology Patient

by Martino, Jessica, Fisher, Brian T., Bosse, Kristopher R., Bagatell, Rochelle
Published in Pediatr Blood Cancer (2015)

Genetic susceptibility to neuroblastoma: current knowledge and future directions

by Ritenour, Laura E., Randall, Michael P., Bosse, Kristopher R., Diskin, Sharon J.
Published in Cell Tissue Res (2018)

Immune-Based Approaches for the Treatment of Pediatric Malignancies

by Bosse, Kristopher R., Majzner, Robbie G., Mackall, Crystal L., Maris, John M.
Published in Annu Rev Cancer Biol (2020)

Acute Renal Injury in a 14-year-old With HIV/AIDS and Tuberculosis

by Bosse, Kristopher R., Russell, Eric A., Chikwava, Kudakwashe R., Rutstein, Richard M., Lowenthal, Elizabeth
Published in Pediatr Infect Dis J (2013)

A Rapid Progression of Disease After Surgical Excision of a Malignant Rhabdoid Tumor of the Bladder

by Sterling, Matthew E., Long, Christopher J., Bosse, Kristopher R., Bagatell, Rochelle, Shukla, Aseem R.
Published in Urology (2015)

Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopes

by Feng, Yang, Wang, Yanping, Zhu, Zhongyu, Li, Wei, Sussman, Robyn T., Randall, Michael, Bosse, Kristopher R., Maris, John M., Dimitrov, Dimiter S.
Published in MAbs (2016)

IMMU-16. TARGETING GLYPICAN 2 (GPC2) ON PEDIATRIC MALIGNANT BRAIN TUMORS WITH MRNA CAR T CELLS

by Foster, Jessica, Griffin, Crystal, Stern, Allison, Brimley, Cameron, Buongervino, Samantha, Storm, Phillip, Barrett, David, Maris, John, Resnick, Adam, Bosse, Kristopher
Published in Neuro Oncol (2021)

Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion

by Bosse, Kristopher R., Shukla, Aseem R., Pawel, Bruce, Chikwava, Kudakwashe R., Santi, Mariarita, Tooke, Laura, Castagna, Katherine, Biegel, Jaclyn A., Bagatell, Rochelle
Published in Cancer Genet (2014)

Rare Variants in TP53 and Susceptibility to Neuroblastoma

by Diskin, Sharon J., Capasso, Mario, Diamond, Maura, Oldridge, Derek A., Conkrite, Karina, Bosse, Kristopher R., Russell, Mike R., Iolascon, Achille, Hakonarson, Hakon, Devoto, Marcella, Maris, John M.
Published 2014

IMMU-04. DEVELOPMENT OF GPC2-DIRECTED CHIMERIC ANTIGEN RECEPTOR THERAPY FOR PEDIATRIC BRAIN TUMORS WITH IN VITRO TRANSCRIBED mRNA

by Foster, Jessica B, Griffin, Crystal, Stern, Allison, Brimley, Cameron, Lane, Maria, Buongervino, Samantha, Dimitrov, Dimiter S, Barrett, David M, Resnick, Adam C, Maris, John M, Bosse, Kristopher R
Published in Neuro Oncol (2019)

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma

by Sussman, Robyn T., Rokita, Jo Lynne, Huang, Kevin, Raman, Pichai, Rathi, Komal S., Martinez, Daniel, Bosse, Kristopher R., Lane, Maria, Hart, Lori S., Bhatti, Tricia, Pawel, Bruce, Maris, John M.
Published in Front Oncol (2020)

LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase

by Chen, Dongdong, Cox, Julie, Annam, Jayabhargav, Weingart, Melanie, Essien, Grace, Rathi, Komal S., Rokita, Jo Lynne, Khurana, Priya, Cuya, Selma M., Bosse, Kristopher R., Pilgrim, Adeiye, Li, Daisy, Shields, Cara, Laur, Oskar, Maris, John M., Schnepp, Robert W.
Published in Neoplasia (2020)

RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma

by Cole, Kristina A., Huggins, Jonathan, Laquaglia, Michael, Hulderman, Chase E., Russell, Mike R., Bosse, Kristopher, Diskin, Sharon J., Attiyeh, Edward F., Sennett, Rachel, Norris, Geoffrey, Laudenslager, Marci, Wood, Andrew C., Mayes, Patrick A., Jagannathan, Jayanti, Winter, Cynthia, Mosse, Yael P., Maris, John M.
Published 2011

A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope

by Raman, Swetha, Buongervino, Samantha N., Lane, Maria V., Zhelev, Doncho V., Zhu, Zhongyu, Cui, Hong, Martinez, Benjamin, Martinez, Daniel, Wang, Yanping, Upton, Kristen, Patel, Khushbu, Rathi, Komal S., Navia, Carmen T., Harmon, Daniel B., Li, Yimei, Pawel, Bruce, Dimitrov, Dimiter S., Maris, John M., Julien, Jean-Philippe, Bosse, Kristopher R.
Published in Cell Rep Med (2021)

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

by Capasso, Mario, Devoto, Marcella, Hou, Cuiping, Asgharzadeh, Shahab, Glessner, Joseph T., Attiyeh, Edward F., Mosse, Yael P., Kim, Cecilia, Diskin, Sharon J., Cole, Kristina A., Bosse, Kristopher, Diamond, Maura, Laudenslager, Marci, Winter, Cynthia, Bradfield, Jonathan P., Scott, Richard H., Jagannathan, Jayanti, Garris, Maria, McConville, Carmel, London, Wendy B., Seeger, Robert C., Grant, Struan F. A., Li, Hongzhe, Rahman, Nazneen, Rappaport, Eric, Hakonarson, Hakon, Maris, John M.
Published 2009

Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform that Influences Neuroblastoma Susceptibility and Oncogenicity

by Bosse, Kristopher R., Diskin, Sharon J., Cole, Kristina A., Wood, Andrew C., Schnepp, Robert W., Norris, Geoffrey, Nguyen, Le B., Jagannathan, Jayanti, Laquaglia, Michael, Winter, Cynthia, Diamond, Maura, Hou, Cuiping, Attiyeh, Edward F., Mosse, Yael P., Pineros, Vanessa, Dizin, Eva, Zhang, Yongqiang, Asgharzadeh, Shahab, Seeger, Robert C., Capasso, Mario, Pawel, Bruce R., Devoto, Marcella, Hakonarson, Hakon, Rappaport, Eric F., Irminger-Finger, Irmgard, Maris, John M.
Published 2012

Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma

by Bosse, Kristopher R., Raman, Pichai, Zhu, Zhongyu, Lane, Maria, Martinez, Daniel, Heitzeneder, Sabine, Rathi, Komal S., Kendsersky, Nathan M., Randall, Michael, Donovan, Laura, Morrissy, Sorana, Sussman, Robyn T., Zhelev, Doncho V., Feng, Yang, Wang, Yanping, Hwang, Jennifer, Garcia, Gonzalo Lopez, Harenza, Jo Lynne, Wei, Jun, Pawel, Bruce, Bhatti, Tricia, Santi, Mariarita, Ganguly, Arupa, Khan, Javed, Marra, Marco A., Taylor, Michael D., Dimitrov, Dimiter S., Mackall, Crystal, Maris, John M.
Published in Cancer Cell (2017)

Copy number variation at 1q21.1 associated with neuroblastoma

by Diskin, Sharon J., Hou, Cuiping, Glessner, Joseph T., Attiyeh, Edward F., Laudenslager, Marci, Bosse, Kristopher, Cole, Kristina, Mosse, Yael P., Wood, Andrew, Lynch, Jill E., Pecor, Katlyn, Diamond, Maura, Winter, Cynthia, Wang, Kai, Kim, Cecilia, Geiger, Elizabeth A., McGrady, Patrick W., Blakemore, Alexandra I. F., London, Wendy B., Shaikh, Tamim H., Bradfield, Jonathan, Grant, Struan F. A., Li, Hongzhe, Devoto, Marcella, Rappaport, Eric R., Hakonarson, Hakon, Maris, John M.
Published 2009